HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Side effects of treatment with the long-acting gonadorelin agonist triptorelin in a case of paraphilia].

Abstract
A 35-year-old man with a paraphilia was treated with long-acting gonadorelin. The desired result was reduced preoccupation with sexuality, but there were various side effects including a serious amount of bone loss. We believe that more attention should be given to the adverse effects of long-term treatment with triptorelin. In our view the drug regimen needs to be revised.
AuthorsJ H Hoogeveen, E van der Veer
JournalTijdschrift voor psychiatrie (Tijdschr Psychiatr) Vol. 49 Issue 2 Pg. 111-5 ( 2007) ISSN: 0303-7339 [Print] Netherlands
Vernacular TitleBijwerkingen van farmacotherapie met de langwerkende gonadorelineagonist triptoreline bij parafilie.
PMID17290340 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone
Topics
  • Adult
  • Bone Density (drug effects)
  • Gonadotropin-Releasing Hormone (agonists)
  • Humans
  • Male
  • Osteoporosis (chemically induced)
  • Paraphilic Disorders (drug therapy)
  • Treatment Outcome
  • Triptorelin Pamoate (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: